INCYTE CORPORATION Net Cash Provided by (Used in) Investing Activities, Continuing Operations
INCYTE CORPORATION (INCY) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$138.82 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-04
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$138.82M, a 582.73% decline year-over-year.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$36.01M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$9.95M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$215.28M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$232.49M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$105.01M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$138.44M.
- INCYTE CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$37.40M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$138.82M 10-Q · filed 2017-05-04 | -$174.83M derived: sum of 2 quarters · filed 2017-05-04 | -$184.78M derived: sum of 3 quarters · filed 2017-05-04 | -$400.06M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | -$36.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$45.96M derived: sum of 2 quarters · filed 2017-02-14 | -$261.25M derived: sum of 3 quarters · filed 2017-02-14 | -$232.49M 10-K · filed 2017-02-14 |
| 2016-09-30 | -$9.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$225.23M derived: sum of 2 quarters · filed 2016-11-01 | -$196.48M 10-Q · filed 2016-11-01 | -$201.00M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-06-30 | -$215.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$186.52M 10-Q · filed 2016-08-09 | -$191.05M derived: sum of 3 quarters · filed 2017-05-04 | -$206.27M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-03-31 | $28.76M 10-Q · filed 2017-05-04 | $24.23M derived: sum of 2 quarters · filed 2017-05-04 | $9.01M derived: sum of 3 quarters · filed 2017-05-04 | -$17.68M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | -$4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$19.74M derived: sum of 2 quarters · filed 2017-02-14 | -$46.44M derived: sum of 3 quarters · filed 2017-02-14 | -$105.01M 10-K · filed 2017-02-14 |
| 2015-09-30 | -$15.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$41.91M derived: sum of 2 quarters · filed 2016-11-01 | -$100.48M 10-Q · filed 2016-11-01 | -$104.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | -$26.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$85.27M 10-Q · filed 2016-08-09 | -$88.78M derived: sum of 3 quarters · filed 2017-02-14 | -$147.47M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | -$58.58M 10-Q · filed 2016-05-09 | -$62.09M derived: sum of 2 quarters · filed 2017-02-14 | -$120.78M derived: sum of 3 quarters · filed 2017-02-14 | -$149.33M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$62.21M derived: sum of 2 quarters · filed 2017-02-14 | -$90.75M derived: sum of 3 quarters · filed 2017-02-14 | -$138.44M 10-K · filed 2017-02-14 |
| 2014-09-30 | -$58.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$87.23M derived: sum of 2 quarters · filed 2015-11-03 | -$134.92M 10-Q · filed 2015-11-03 | -$154.85M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | -$28.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$76.23M 10-Q · filed 2015-08-04 | -$96.16M derived: sum of 3 quarters · filed 2016-02-12 | -$97.17M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$47.69M 10-Q · filed 2015-04-30 | -$67.62M derived: sum of 2 quarters · filed 2016-02-12 | -$68.62M derived: sum of 3 quarters · filed 2016-02-12 | -$84.33M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | -$19.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$20.94M derived: sum of 2 quarters · filed 2016-02-12 | -$36.64M derived: sum of 3 quarters · filed 2016-02-12 | -$37.40M 10-K · filed 2016-02-12 |
| 2013-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$16.70M derived: sum of 2 quarters · filed 2014-10-30 | -$17.46M 10-Q · filed 2014-10-30 | -$17.96M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | -$15.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$16.46M 10-Q · filed 2014-07-31 | -$16.96M derived: sum of 3 quarters · filed 2015-02-17 | -$17.21M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | -$758.00K 10-Q · filed 2014-05-01 | -$1.26M derived: sum of 2 quarters · filed 2015-02-17 | -$1.51M derived: sum of 3 quarters · filed 2015-02-17 | -$2.42M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$749.00K derived: sum of 2 quarters · filed 2015-02-17 | -$1.66M derived: sum of 3 quarters · filed 2015-02-17 | -$1.99M 10-K · filed 2015-02-17 |
| 2012-09-30 | -$249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$1.16M derived: sum of 2 quarters · filed 2013-10-31 | -$1.49M 10-Q · filed 2013-10-31 | -$2.63M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | -$910.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$1.24M 10-Q · filed 2013-08-01 | -$2.38M derived: sum of 3 quarters · filed 2014-02-21 | -$3.22M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | -$329.00K 10-Q · filed 2013-05-02 | -$1.47M derived: sum of 2 quarters · filed 2014-02-21 | -$2.31M derived: sum of 3 quarters · filed 2014-02-21 | -$2.85M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$1.98M derived: sum of 2 quarters · filed 2014-02-21 | -$2.52M derived: sum of 3 quarters · filed 2014-02-21 | -$2.50M 10-K · filed 2014-02-21 |
| 2011-09-30 | -$841.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$1.39M derived: sum of 2 quarters · filed 2012-11-01 | -$1.36M 10-Q · filed 2012-11-01 | -$3.20M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | -$545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$521.00K 10-Q · filed 2012-08-03 | -$2.36M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2011-03-31 | $24.00K 10-Q · filed 2012-04-26 | -$1.82M derived: sum of 2 quarters · filed 2013-02-21 | ||
| 2010-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $15.20M 10-K · filed 2013-02-21 | ||
| 2010-09-30 | $17.05M 10-Q · filed 2011-10-27 | |||
| 2009-12-31 | $16.45M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |